These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27837441)

  • 1. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
    Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
    Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.
    Shabnaz S; Ahmed MU; Islam MS; Islam MR; Al-Mamun MM; Islam MS; Hasnat A
    Tumour Biol; 2016 Jun; 37(6):7229-37. PubMed ID: 26666818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of TP53 codon 72 and CDH1 genetic polymorphisms with colorectal cancer risk in Bangladeshi population.
    Rivu SF; Apu MNH; Shabnaz S; Nahid NA; Islam MR; Al-Mamun MMA; Nahar Z; Rabbi SNI; Ahmed MU; Islam MS; Hasnat A
    Cancer Epidemiol; 2017 Aug; 49():46-52. PubMed ID: 28554075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 genetic polymorphisms and susceptibility to cervical cancer in Bangladeshi women: a case-control study.
    Apu MNH; Rashed AZM; Bashar T; Rahman MM; Mostaid MS
    Mol Biol Rep; 2020 Jun; 47(6):4357-4364. PubMed ID: 32424519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
    Nairuz T; Rahman M; Bushra MU; Kabir Y
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
    Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
    Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
    Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A
    Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 codon 72 polymorphism interactions with dietary and tobacco related habits and risk of stomach cancer in Mizoram, India.
    Malakar M; Devi KR; Phukan RK; Kaur T; Deka M; Puia L; Sailo L; Lalhmangaihi T; Barua D; Rajguru SK; Mahanta J; Narain K
    Asian Pac J Cancer Prev; 2014; 15(2):717-23. PubMed ID: 24568485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation.
    Hao W; Xu X; Shi H; Zhang C; Chen X
    Eur J Med Res; 2018 Oct; 23(1):47. PubMed ID: 30309383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of polymorphisms in codons 11, 72 and 248 of TP53 in Brazilian women with breast cancer.
    Almeida BC; Kleine JP; Camargo-Kosugi CM; Lisboa MR; França CN; França JP; Silva ID
    Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis.
    Jafrin S; Aziz MA; Anonna SN; Akter T; Naznin NE; Reza S; Islam MS
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1511-1519. PubMed ID: 32592343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of TP53 gene polymorphisms with susceptibility of bladder cancer in Bangladeshi population.
    Hosen MB; Salam MA; Islam MF; Hossain A; Hawlader MZ; Kabir Y
    Tumour Biol; 2015 Aug; 36(8):6369-74. PubMed ID: 25801242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 exon 4 (codon 72) polymorphism and exon 7 (codon 249) mutation in breast cancer patients in southern region (Madurai) of Tamil Nadu.
    Vijayaraman KP; Veluchamy M; Murugesan P; Shanmugiah KP; Kasi PD
    Asian Pac J Cancer Prev; 2012; 13(2):511-6. PubMed ID: 22524816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 codon 72 and HER2 codon 655 polymorphisms in Turkish breast cancer patients.
    Kara N; Karakus N; Ulusoy AN; Ozaslan C; Gungor B; Bagci H
    DNA Cell Biol; 2010 Jul; 29(7):387-92. PubMed ID: 20380571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
    Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO
    Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
    Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
    Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.
    Volodko N; Salla M; Eksteen B; Fedorak RN; Huynh HQ; Baksh S
    World J Gastroenterol; 2015 Sep; 21(36):10358-66. PubMed ID: 26420962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 codon 72 polymorphism is associated with pancreatic cancer risk in males, smokers and drinkers.
    Sonoyama T; Sakai A; Mita Y; Yasuda Y; Kawamoto H; Yagi T; Yoshioka M; Mimura T; Nakachi K; Ouchida M; Yamamoto K; Shimizu K
    Mol Med Rep; 2011; 4(3):489-95. PubMed ID: 21468597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects.
    Ma Y; Yang J; Liu Z; Zhang P; Yang Z; Wang Y; Qin H
    Breast Cancer Res Treat; 2011 Jan; 125(1):201-5. PubMed ID: 20496166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.